ZHG-23442-81989
2 vaccinations
5 coded responses
17 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 292 / SC
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Pfizer-BioNTech
-
2021-04-08
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Tenderness — Feeling: Good · Site: RednessFree text: Redness is slightly below injection site and think developed day 2 , very slight tenderness. No indurationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site warmth — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Have an area of redness, some warmth snd tenderness about an inch or two below where I think the injection was givenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Erythema, Injection site pain, Injection site pruritus, Injection site warmth — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: About 2 inches below injection site and begin about 24 hr after first injection got erythema, warmth, tenderness- this is decreasing. And sporadic itching. Erythema is slightly increased in size. Note this is all about 2 inches below the injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-15
- 2021-04-22
-
2021-04-29
Dose 2 — Pfizer-BioNTech
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-06-03
-
2021-10-30
Survey response — 6 months, dose 2MedDRA: Fall — Feeling: Good · Be unable to do your normal daily activitiesFree text: Falling - doubt relates to CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-02-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-13 | Unsuccessful |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): No
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Redness is slightly below injection site and think developed day 2 , very slight tenderness. No induration
Systemic reaction (other): Have an area of redness, some warmth snd tenderness about an inch or two below where I think the injection was given
Systemic reaction (other): About 2 inches below injection site and begin about 24 hr after first injection got erythema, warmth, tenderness- this is decreasing. And sporadic itching. Erythema is slightly increased in size. Note this is all about 2 inches below the injection site.
Release 10 — 6 months, dose 2
Symptoms: Falling - doubt relates to Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fall | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release